GlassScriptPhysician profile
Evan G Black
NPI 1346260247
$14,572.15
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $155 · 2021: $115.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $13,658.65 | 2019 | |
| Genzyme Corporation | $202.24 | 2019-2020 | |
| Emd Serono, INC. | $132.24 | 2019-2020 | |
| Boston Scientific Corporation | $115.31 | 2021 | |
| Novartis Pharmaceuticals Corporation | $97.00 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $53.67 | 2019-2020 | |
| Amgen INC. | $48.47 | 2019 | |
| Biogen, INC. | $40.86 | 2019 | |
| Lilly USA, LLC | $40.54 | 2019-2020 | |
| Livanova USA, INC. | $34.20 | 2020 | |
| Acadia Pharmaceuticals INC | $31.20 | 2019 | |
| Janssen Pharmaceuticals, INC | $29.52 | 2019 | |
| Amneal Pharmaceuticals LLC | $27.43 | 2019 | |
| Lundbeck LLC | $24.20 | 2019 | |
| Ucb, INC. | $22.62 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acorda Therapeutics, INC | $14.00 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.